Warri; Anni

Patent Applications and Registrations

Patent applications and USPTO patent grants for Warri; Anni.The latest application filed is for "reversal of high breast cancer risk in mammals exposed to estrogenic chemicals in utero by adult exposure to hdac and dnmt inhibitors".

Company Profile

0.4.5

Warri; Anni - Bethesda MD
Warri; Anni - Lieto FI
Warri, Anni - Espoo FI
Warri; Anni - 21420 Lieto FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Reversal Of High Breast Cancer Risk In Mammals Exposed To Estrogenic Chemicals In Utero By Adult Exposure To Hdac And Dnmt Inhibitors App 20130324543 - Hilakivi-Clarke; Leena ; et al.	2013-12-05
Food product comprising hydroxymatairesinol Grant 7,005,447 - Ahotupa , et al. February 28, 2	2006-02-28
Prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by use of hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol App 20040048804 - Ahotupa, Markku ; et al.	2004-03-11
Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol Grant 6,689,809 - Ahotupa , et al. February 10, 2	2004-02-10
Remedy for autoimmune diseases App 20020107231 - Itoh, Junpei ; et al.	2002-08-08
Prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by use of hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol App 20020061854 - Ahotupa, Markku ; et al.	2002-05-23
Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol App 20010016590 - Ahotupa, Markku ; et al.	2001-08-23
Remedy for autoimmune diseases Grant 5,886,049 - Itoh , et al. March 23, 1	1999-03-23
Syndecan stimulation of cellular differentiation Grant 5,726,058 - Jalkanen , et al. March 10, 1	1998-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.